Musaffa Logo
BRAIN Biotech AG BNN.DE
€2.83 €0.05 (1.80%) 1D

Last Updated: Aug 10, 12:00 AM·XETRA

Pricing for DE stocks is delayed by 24 hours

BNN.DE Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, BRAIN Biotech AG is classified as halal.

HALAL

Report Source: undefined Quarter Report

BRAIN Biotech AG

BRAIN Biotech AG. Stock Analysis BNN.DE

Germany Materials Micro Cap

BRAIN Biotech AG (BNN.DE) Chart

Financial Metrics & Statements of BRAIN Biotech AG (BNN.DE)

FAQ's for BRAIN Biotech AG (BNN.DE)

  • As of August 2026, BRAIN Biotech AG BNN.DE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BRAIN Biotech AG using these criteria to determine its compliance status.
  • Muslim investors may consider investing in BRAIN Biotech AG if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of BRAIN Biotech AG by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of BRAIN Biotech AG may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of BRAIN Biotech AG on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.